Wire Stories
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI� (brexpiprazole) for the Treatment of Agitation Associated with Alzheimer�s Dementia
The Prescription Drug User Fee Act (PDUFA) target action date is May 10, 2023 PRINCETON, N.J. & DEERFIELD, Ill.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development...